These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 30851166)
21. Seven-day quintuple regimen as a rescue therapy for Helicobacter pylori eradication. Mansour-Ghanaei F; Joukar F; Naghipour MR; Forouhari A; Saadat SM World J Gastroenterol; 2015 Jan; 21(2):661-6. PubMed ID: 25593496 [TBL] [Abstract][Full Text] [Related]
22. Quadruple, sequential, and concomitant first-line therapies for H. pylori eradication: a prospective, randomized study. De Francesco V; Pontone S; Bellesia A; Serviddio G; Panetta C; Palma R; Zullo A Dig Liver Dis; 2018 Feb; 50(2):139-141. PubMed ID: 29089267 [TBL] [Abstract][Full Text] [Related]
23. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia. Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102 [TBL] [Abstract][Full Text] [Related]
24. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication. Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386 [TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Bonfigli AR; Boemi M; Festa R; Bonazzi P; Brandoni G; Spazzafumo L; Olivieri F; Ceriello A; Genovese S; Testa R Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):893-8. PubMed ID: 27480449 [TBL] [Abstract][Full Text] [Related]
26. [A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]. Huang J; Gong ST; Ou WJ; Pan RF; Geng LL; Huang H; He WE; Chen PY; Liu LY; Zhou LY Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):563-7. PubMed ID: 23158730 [TBL] [Abstract][Full Text] [Related]
27. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients. Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530 [TBL] [Abstract][Full Text] [Related]
28. Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients. Yang X; Tan P; Song L; Lu Z Am J Ther; 2016; 23(6):e1436-e1441. PubMed ID: 25923229 [TBL] [Abstract][Full Text] [Related]
29. Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection. Puig I; González-Santiago JM; Molina-Infante J; Barrio J; Herranz MT; Algaba A; Castro M; Gisbert JP; Calvet X Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869699 [TBL] [Abstract][Full Text] [Related]
30. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. Paoluzi OA; Visconti E; Andrei F; Tosti C; Lionetti R; Grasso E; Ranaldi R; Stroppa I; Pallone F J Clin Gastroenterol; 2010 Apr; 44(4):261-6. PubMed ID: 20195162 [TBL] [Abstract][Full Text] [Related]
31. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study. Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989 [TBL] [Abstract][Full Text] [Related]
32. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication. Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166 [TBL] [Abstract][Full Text] [Related]
33. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients. Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262 [TBL] [Abstract][Full Text] [Related]
34. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area. Georgopoulos SD; Xirouchakis E; Martinez-Gonzales B; Zampeli E; Grivas E; Spiliadi C; Sotiropoulou M; Petraki K; Zografos K; Laoudi F; Sgouras D; Mentis A; Kasapidis P; Michopoulos S Eur J Intern Med; 2016 Jul; 32():84-90. PubMed ID: 27134145 [TBL] [Abstract][Full Text] [Related]
35. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study. Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938 [TBL] [Abstract][Full Text] [Related]
36. Optimizing first line 7-day standard triple therapy for Helicobacter pylori eradication: Prolonging treatment or adding bismuth: which is better? Leow AH; Azmi AN; Loke MF; Vadivelu J; Graham DY; Goh KL J Dig Dis; 2018 Nov; 19(11):674-677. PubMed ID: 30307122 [TBL] [Abstract][Full Text] [Related]
37. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Greenberg ER; Anderson GL; Morgan DR; Torres J; Chey WD; Bravo LE; Dominguez RL; Ferreccio C; Herrero R; Lazcano-Ponce EC; Meza-Montenegro MM; Peña R; Peña EM; Salazar-Martínez E; Correa P; Martínez ME; Valdivieso M; Goodman GE; Crowley JJ; Baker LH Lancet; 2011 Aug; 378(9790):507-14. PubMed ID: 21777974 [TBL] [Abstract][Full Text] [Related]
38. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan. Tsay FW; Tseng HH; Hsu PI; Wang KM; Lee CC; Chang SN; Wang HM; Yu HC; Chen WC; Peng NJ; Lai KH; Wu DC J Gastroenterol Hepatol; 2012 Mar; 27(3):498-503. PubMed ID: 21871025 [TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication. Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N World J Gastroenterol; 2015 May; 21(18):5568-74. PubMed ID: 25987781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]